Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: The Australian AIDS cohort

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 16, Issue 1, 1997, Pages 39-43

  Dore, Gregory J ^a   Hoy, Jennifer F ^b   Mallal, Simon A ^c   Li, Yueming ^a   Mijch, Anne M ^b   French, Martyn A ^c   Cooper, David A ^a,d   Kaldor, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b AIDS Unit Fairfield Infect Diseases Hospital   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

AIDS; Australia; Opportunistic infections; Time trends

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; CYTOMEGALOVIRUS; FEMALE; HOMOSEXUALITY; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AVIUM; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT;

EID: 0030815454     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199709010-00006     Document Type: Article

References (19)

1. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. N Engl J Med 1993; 329:1922-6.
2. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985-1991. Am J Epidemiol 1993;137:423-38.
3. Wall PG, Porter K, Noone A, Goldberg DJ. Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United Kingdom. AIDS 1993;7:1523-5.
4. Montaner JSG, Le T, Hogg R, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994;8:693-6.
5. Delmas MC, Schwoebel V, Heisterkamp SH, Downs AM, Ancelle-Park RA, Brunet JB. Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries: coordinators for AIDS Surveillance. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:74-80.
6. Kaiz MH, Hessol NA, Buchbinder SP, et al. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994;170:198-202
7. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morbid Mortal Wkly Rep 1987;36(Suppl 1S):3S-5S.
8. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS. MMWR Morbid Mortal Wkly Rep 1992;41(RR-17):1-19.
9. Tibshirani R. A plain man's guide to the proportional hazards model. Clin Invest Med 1982;5:63-8.
10. National Centre in HIV Epidemiology and Clinical Research. Australian HIV Surveillance Rep 1995;11:2.
11. Gallant JE, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7.
12. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082-5.
13. Hoover DR, Black C, Jacobson LP, et al. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 1993;138:266-78.
14. Mocroft AJ, Johnson MA, Sabin CA, et al. Staging system for clinical AIDS patients. Lancet 1995;346:12-17.
15. Chang Y, Cesarman E, Pessin MS, et al. Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
16. Marriott DJ, Jones PD, Hoy JF, Speed BR, Harkness JL. Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients: a double-blinded placebocontrolled study. Med J Aust 1993;158:312-6.
17. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
18. Powderly WG, Finkelstein DM, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332:700-5.
19. Spector SA, McKinley GF, Lalezan JP, et al. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS: Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med 1996;334:1491-7.